Dr Jun Hu, a researcher at the University of Akron, has made a major breakthrough in the use of non-invasive technology for continuous blood glucose monitoring in diabetic patients using a contact lens and smartphone application. Users simply wear a contact lens throughout the day and if at any point their body is not properly […]
Tag: Echo Therapeutics
Echo Therapeutics denied FDA approval for Prelude transdermal drug delivery platform, at least for now
Echo Therapeutics Prelude Skin Prep System is referred to DHHS Combination Products Department, indefinitely delaying product launch in US.
Despite hype, new non-invasive glucose monitor by Echo Therapeutics is not supported by clinical data
A look at Echo Therapeutics, their products and commentary about the future of the company.